Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Birch triterpenes by Chiesi Farmaceutici for Radiodermatitis: Likelihood of Approval
Birch triterpenes is under clinical development by Chiesi Farmaceutici and currently in Phase II for Radiodermatitis. According to GlobalData, Phase...